Gelonghui, April 9 | Saisheng Pharmaceutical (300485.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 477 million yuan, a year-on-year decrease of 35.12%; net profit attributable to shareholders of listed companies was 103 million yuan, a year-on-year decrease of 49.73%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses; basic earnings per share of 0.21 yuan; it plans to distribute a cash dividend of 0.22 yuan (tax included) for every 10 shares to all shareholders.
赛升药业(300485.SZ)：2023年度净利润降49.73%至1.03亿元 拟10派0.22元
Saisheng Pharmaceutical (300485.SZ): Net profit for 2023 decreased by 49.73% to 103 million yuan, plans to distribute 10 to 0.22 yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.